Prestige Consumer Healthcare Inc (NYSE:PBH)
$ 50.52 -1.16 (-2.24%) Market Cap: 2.39 Bil Enterprise Value: 4.37 Bil PE Ratio: 14.15 PB Ratio: 1.25 GF Score: 69/100

Q3 2026 Prestige Consumer Healthcare Inc Earnings Call Transcript

Feb 05, 2026 / 01:30PM GMT
Release Date Price: $65.55 (-2.21%)

Key Points

Positve
  • Prestige Consumer Healthcare Inc (PBH) delivered solid third-quarter results with sales of $283 million, slightly better than forecasted.
  • The company maintained a strong gross margin of 55.5% and an adjusted EPS of $1.14, in line with expectations.
  • Free cash flow increased by 13% year-to-date, reaching $209 million, allowing for strategic investments and share repurchases.
  • The acquisition of Pillar5 is expected to enhance supply chain control and improve production efficiency for the Clear Eye brand.
  • E-commerce channels showed strong growth, with over 10% consumption increase in the third quarter, reflecting adaptability to changing consumer shopping habits.
Negative
  • Third-quarter revenue declined by 2.4% compared to the previous year, primarily due to supply constraints in the eye and ear care categories.
  • Adjusted diluted EPS decreased slightly from $1.22 to $1.14 year-over-year, impacted by lower sales and higher G&A costs.
  • The company faced challenges with a $10 million write-off of a supplier loan, reflecting risks in supplier financial stability.
  • The women's health segment experienced volatility, with sequential improvement but still facing challenges in consumer shopping patterns.
  • The analgesics category was negatively impacted by public announcements related to acetaminophen, affecting sales performance.
Operator

Good day and thank you for standing by. Welcome to the third quarter, 2026, Prestige Consumer Healthcare Inc. earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your speaker today, Philip Terpolilli, Vice President of Investor Relations and Treasury. Please go ahead.

Phil Terpolilli
Prestige Consumer Healthcare Inc - Vice President of Investor Relations and Treasury

Thanks, operator, and thank you to everyone who has joined today. On the call with me are Ron Lombardi, our Chairman, President, and CEO; and Chris Sacco, our CFO and COO.

On today's call, we'll review our third quarter fiscal 2026 results, discuss our full year outlook, and then take questions from analysts. The slide presentation accompanies today's call can be accessed by visiting prestigeconsumerhealthcare.com, clicking on the investors link, and then on today's webcast and presentation.

Remember, some of the information contained in the presentation today

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot